Medifast Q1 2025: revenue down 34% to $115.7M, net loss $0.8M; Q2 guidance weak

MEDIFAST INC

2025-Q1 EPS reported -$0.07 revenue$115,728,000

Revenue fell 33.8% to $115.7M; active earning coaches down 32.8% to 25,400.
Net loss of $0.8M vs. net income of $8.3M a year ago; diluted EPS -$0.07.
Gross margin held at 72.8%; operating loss $1.3M vs. operating income $7.9M.
Q2 2025 revenue guidance $85M-$105M; loss per share $0.00-$0.55.
Cash, equivalents, and investments $164.6M; no debt.

item 2.02 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001628280-25-020336
form_type: 8-K
ticker: MED
cik: 0000910329
company_name: MEDIFAST INC
filed_at: 2025-04-28T23:59:59+00:00
discovered_at: 2026-05-14T18:02:51.765628+00:00
generated_at: 2026-05-23T05:33:10.717709+00:00
sec_items: ["2.02", "9.01"]
event_type: earnings
sentiment: negative
materiality_score: 0.85
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001628280-25-020336
json_url: https://secwatch.observer/filing/0001628280-25-020336.json
markdown_url: https://secwatch.observer/filing/0001628280-25-020336.md
text_url: https://secwatch.observer/filing/0001628280-25-020336.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/910329/000162828025020336/0001628280-25-020336-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/910329/000162828025020336/med-20250428.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001628280-25-020336

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.